Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia | BMJ Case Reports

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Global health

Authors

About

Help
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Case report

Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia

Online download statistics by month:

Online download statistics by month: December 2021 to April 2024

	Abstract	Full	Pdf
Dec 2021	968	13	9
Jan 2022	672	32	13
Feb 2022	352	12	12
Mar 2022	262	5	4
Apr 2022	118	5	1
May 2022	130	2	2
Jun 2022	80	6	1
Jul 2022	78	4	1
Aug 2022	60	4	3
Sep 2022	81	6	2
Oct 2022	59	6	1
Nov 2022	25	3	0
Dec 2022	53	5	0
Jan 2023	32	1	1
Feb 2023	96	0	0
Mar 2023	36	4	1
Apr 2023	33	4	0
May 2023	31	1	1
Jun 2023	32	4	3
Jul 2023	43	5	1
Aug 2023	72	4	1
Sep 2023	68	2	4
Oct 2023	40	4	3
Nov 2023	46	6	5
Dec 2023	32	2	4
Jan 2024	12	4	2
Feb 2024	53	2	3
Mar 2024	24	5	2
Apr 2024	27	1	1
Total	3615	152	81